scholarly journals c-Kit Is Suppressed in Human Colon Cancer Tissue and Contributes to L1-Mediated Metastasis

2013 ◽  
Vol 73 (18) ◽  
pp. 5754-5763 ◽  
Author(s):  
Nancy Gavert ◽  
Anna Shvab ◽  
Michal Sheffer ◽  
Amir Ben-Shmuel ◽  
Gal Haase ◽  
...  
2011 ◽  
Vol 38 (9) ◽  
pp. 0904001
Author(s):  
席刚琴 Xi Gangqin ◽  
陈燕坪 Chen Yanping ◽  
陈刚 Chen Gang ◽  
郑雄伟 Zheng Xiongwei ◽  
冯尚源 Feng Shangyuan ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-5 ◽  
Author(s):  
Ninna C. S. Voss ◽  
Henrik Kold-Petersen ◽  
Mikkel B. Henningsen ◽  
Casper Homilius ◽  
Ebbe Boedtkjer

Increased metabolism accelerates local acid production in cancer tissue. The mechanisms eliminating acidic waste products from human colon cancer tissue represent promising therapeutic targets for pharmacological manipulation in order to improve prognosis for the increasing number of patients with colon cancer. We sampled biopsies of human colonic adenocarcinomas and matched normal colon tissue from patients undergoing colon cancer surgery. We measured steady-state intracellular pH and rates of net acid extrusion in freshly isolated human colonic crypts based on fluorescence microscopy. Net acid extrusion was almost entirely (>95%) Na+-dependent. The capacity for net acid extrusion was increased and steady-state intracellular pH elevated around 0.5 in crypts from colon cancer tissue compared with normal colon tissue irrespective of whether they were investigated in the presence or absence of CO2/HCO3–. The accelerated net acid extrusion from the human colon cancer tissue was sensitive to the Na+/H+-exchange inhibitor cariporide. We conclude that enhanced net acid extrusion via Na+/H+-exchange elevates intracellular pH in human colon cancer tissue.


2016 ◽  
Vol 61 (8) ◽  
pp. 711-720 ◽  
Author(s):  
Lei Ding ◽  
Liyong Wang ◽  
Leiming Sui ◽  
Huanying Zhao ◽  
Xiaoxue Xu ◽  
...  

2000 ◽  
Vol 118 (4) ◽  
pp. A1392
Author(s):  
Jeong Wook Kim ◽  
Seoung Hyeock Han ◽  
Hyun Joo Jeong ◽  
Jae Hyuk Do ◽  
Sae Kyung Chang

2019 ◽  
Vol 316 (1) ◽  
pp. H245-H254 ◽  
Author(s):  
Ninna C. S. Voss ◽  
Henrik Kold-Petersen ◽  
Ebbe Boedtkjer

Inadequate perfusion of solid cancer tissue results in low local nutrient and oxygen levels and accumulation of acidic waste products. Previous investigations have focused primarily on tumor blood vessel architecture, and we lack information concerning functional differences between arteries that deliver blood to solid cancer tissue versus normal tissue. Here, we use isometric myography to study resistance-sized arteries from human primary colon adenocarcinomas and matched normal colon tissue. Vasocontraction of colon cancer feed arteries in response to endothelin-1 and thromboxane stimulation is attenuated compared with normal colon arteries despite similar wall dimensions and comparable contractions to arginine vasopressin and K+-induced depolarization. Acetylcholine-induced vasorelaxation and endothelial NO synthase expression are increased in colon cancer feed arteries compared with normal colon arteries, whereas vasorelaxation to exogenous NO donors is unaffected. In congruence, the differences in vasorelaxant and vasocontractile function between colon cancer feed arteries and normal colon arteries decrease after NO synthase inhibition. Rhythmic oscillations in vascular tone, known as vasomotion, are of lower amplitude but similar frequency in colon cancer feed arteries compared with normal colon arteries. In conclusion, higher NO synthase expression and elevated NO signaling amplify vasorelaxation and attenuate vasocontraction of human colon cancer feed arteries. We propose that enhanced endothelial function augments tumor perfusion and represents a potential therapeutic target. NEW & NOTEWORTHY Local vascular resistance influences tumor perfusion. Arteries supplying human colonic adenocarcinomas show enhanced vasorelaxation and reduced vasocontraction mainly due to elevated nitric oxide-mediated signaling. Rhythmic oscillations in tone, known as vasomotion, are attenuated in colon cancer feed arteries.


Surgery Today ◽  
1993 ◽  
Vol 23 (5) ◽  
pp. 420-423 ◽  
Author(s):  
Toshiharu Furukawa ◽  
Tetsuro Kubota ◽  
Masahiko Watanabe ◽  
Tsong-Hong Kuo ◽  
Hideki Nishibori ◽  
...  

Cancers ◽  
2020 ◽  
Vol 12 (7) ◽  
pp. 1913
Author(s):  
Noëlle Dommann ◽  
Daniel Sánchez-Taltavull ◽  
Linda Eggs ◽  
Fabienne Birrer ◽  
Tess Brodie ◽  
...  

Colorectal cancer, along with its high potential for recurrence and metastasis, is a major health burden. Uncovering proteins and pathways required for tumor cell growth is necessary for the development of novel targeted therapies. Ajuba is a member of the LIM domain family of proteins whose expression is positively associated with numerous cancers. Our data shows that Ajuba is highly expressed in human colon cancer tissue and cell lines. Publicly available data from The Cancer Genome Atlas shows a negative correlation between survival and Ajuba expression in patients with colon cancer. To investigate its function, we transduced SW480 human colon cancer cells, with lentiviral constructs to knockdown or overexpress Ajuba protein. The transcriptome of the modified cell lines was analyzed by RNA sequencing. Among the pathways enriched in the differentially expressed genes, were cell proliferation, migration and differentiation. We confirmed our sequencing data with biological assays; cells depleted of Ajuba were less proliferative, more sensitive to irradiation, migrated less and were less efficient in colony formation. In addition, loss of Ajuba expression decreased the tumor burden in a murine model of colorectal metastasis to the liver. Taken together, our data supports that Ajuba promotes colon cancer growth, migration and metastasis and therefore is a potential candidate for targeted therapy.


2005 ◽  
Vol 33 (4) ◽  
pp. 733-735 ◽  
Author(s):  
K. Daly ◽  
M.A. Cuff ◽  
F. Fung ◽  
S.P. Shirazi-Beechey

The transition from normality to malignancy in colorectal cancer is characterized by alterations in the expression of genes associated with the maintenance of tissue homoeostasis. Butyrate, a product of microbial fermentation of dietary fibre in the colon, is known to regulate a number of genes associated with the processes of proliferation, differentiation and apoptosis of colonic epithelial cells, and, hence, homoeostasis of colonic tissue. We have shown previously that the transport of butyrate into colonocytes is of fundamental importance to butyrate's regulatory ability, and therefore sought to assess the expression profile of butyrate-responsive genes in colon cancer tissue, where the expression of the colonic luminal-membrane butyrate transporter, MCT1 (monocarboxylate transporter 1), is significantly down-regulated. In the present paper, we first employed microarray analysis to assess global changes in butyrate-responsive genes using HT29 human colon carcinoma cells treated with butyrate. There was consistency in the butyrate response of selected genes in two other human colonic cell lines (HCT116 and AA/C1) using quantitative real-time PCR. Furthermore, we report that expression levels of selected butyrate-responsive genes involved in the processes of proliferation, differentiation and apoptosis, are deregulated in colon cancer tissue, correlating with decreased expression of MCT1. These findings support our hypothesis that a reduction in MCT1 expression, and hence butyrate transport, can lead to a reduction in the intracellular butyrate levels required to regulate gene expression. Collectively, our results highlight the important contribution of butyrate transport to the maintenance of tissue homoeostasis and disease prevention.


Sign in / Sign up

Export Citation Format

Share Document